Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Orchid Chemicals and Pharmaceuticals Ltd
Orchid Chemicals and Pharmaceuticals Ltd
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part I
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
Resolving capping issues in tablet manufacturing
Natoli explores the various causes of capping and the methods to prevent it
Effective ways to optimise heat exchangers
Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Upcoming event
Lounges
23-25 April 2024 | Conference | Messe Karlsruhe, Germany
See all
Related Content
Finance
Hospira completes purchase of Orchid\'s API manufacturing and R&D facility
US$218m acquisition paves way for future development
Pharmaceutical
Indian manufacturers set to cash in on US generics market
Indian pharma companies are well positioned to generate strong revenues from the US generics market
Pharmaceutical
New anti-infectives company formed
Allecra Therapeutics to develop novel antibiotics to combat multi drug-resistant bacterial infections
You need to be a subscriber to read this article.
Click here
to find out more.
Finance
Mega deals and job cuts
Mergers and acquisitions, job cuts as companies streamlined their operations and cut costs, and investments in new plants were the main features of the pharmaceutical industry in 2012
Ingredients
Hospira to buy API manufacturing and r&d facilities in India
Purchase from Orchid will support continuity of antibiotic API supply
Finance
Hospira completes acquisition of Orchid's generic injectables business
Gains new manufacturing capabilities and expands global reach
Subscribe now